Symptom burden: multiple symptoms and their impact as patient-reported outcomes
The NIHR 'Be Part of Research' portal and ClinicalTrials.gov list current recruitment opportunities for investigational obesity studies
Schedule: Weekly subcutaneous injections for 1248 weeks (clinical trials ranged 3648 weeks) [2]
Semisynthetic, site-specific ubiquitin modification of -synuclein reveals differential effects on aggregation
Investigate the mechanisms by which BDCMs enhance electrocatalytic activities, characterizing the interactions between active sites and BDC carriers, as well as interfacial reaction kinetics, using advanced multiscale simulations, visual modeling, and in situ/operando characterization methods such as DFT calculations, COMSOL, synchrotron X-ray diffraction, and neutron diffraction
The position of the two domains of the protein with respect to each other is seen to be crucial in the formation of the active site cleft of the enzyme